151 related articles for article (PubMed ID: 19932908)
1. Hepatocellular carcinoma associated lipid metabolism reprogramming.
Skill NJ; Scott RE; Wu J; Maluccio MA
J Surg Res; 2011 Jul; 169(1):51-6. PubMed ID: 19932908
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
Lou L; Chen YX; Jin L; Li X; Tao X; Zhu J; Chen X; Wu S; Ye W; He J; Ding G
J Int Med Res; 2013 Feb; 41(1):55-63. PubMed ID: 23569130
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
[TBL] [Abstract][Full Text] [Related]
6. [
Kwee SA; Sato MM; Kuang Y; Franke A; Custer L; Miyazaki K; Wong LL
Mol Imaging Biol; 2017 Jun; 19(3):446-455. PubMed ID: 27787742
[TBL] [Abstract][Full Text] [Related]
7. Implications of the lysophosphatidic acid signaling axis in liver cancer.
Lopane C; Agosti P; Gigante I; Sabbà C; Mazzocca A
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):277-282. PubMed ID: 28591560
[TBL] [Abstract][Full Text] [Related]
8. A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells.
Rivas Serna IM; Romito I; Maugeri A; Lo Re O; Giallongo S; Mazzoccoli G; Oben JA; Li Volti G; Mazza T; Alisi A; Vinciguerra M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182805
[TBL] [Abstract][Full Text] [Related]
9. Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.
Wu JM; Skill NJ; Maluccio MA
HPB (Oxford); 2010 Nov; 12(9):625-36. PubMed ID: 20961371
[TBL] [Abstract][Full Text] [Related]
10. Lysophospholipid variants in hepatocellular carcinoma.
Skill NJ; Jianmin W; Yan X; Zhao Z; Tector AJ; Maluccio MA
J Surg Res; 2013 Jun; 182(2):241-9. PubMed ID: 23158405
[TBL] [Abstract][Full Text] [Related]
11. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
12. High expression of Janus kinase 2 in background normal liver tissue of resected hepatocellular carcinoma is associated with worse prognosis.
Sonohara F; Nomoto S; Inokawa Y; Hishida M; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
Oncol Rep; 2015 Feb; 33(2):767-73. PubMed ID: 25420511
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
[TBL] [Abstract][Full Text] [Related]
14. Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation.
Takahashi T; Deuschle U; Taira S; Nishida T; Fujimoto M; Hijikata T; Tsuneyama K
Hepatol Int; 2018 May; 12(3):254-261. PubMed ID: 29651702
[TBL] [Abstract][Full Text] [Related]
15. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
Ramesh V; Ganesan K
Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
[TBL] [Abstract][Full Text] [Related]
16. Temporal correlation of pathology and DNA damage with gene expression in a choline-deficient model of rat liver injury.
Powell CL; Kosyk O; Bradford BU; Parker JS; Lobenhofer EK; Denda A; Uematsu F; Nakae D; Rusyn I
Hepatology; 2005 Nov; 42(5):1137-47. PubMed ID: 16250055
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
Skill N; Wu J; Xu Y; Zhao Z; Maluccio M
Cancer Invest; 2013 Feb; 31(2):145-55. PubMed ID: 23362952
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
19. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
Liang J; Lv J; Liu Z
Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
[TBL] [Abstract][Full Text] [Related]
20. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.
Yamashita T; Honda M; Takatori H; Nishino R; Minato H; Takamura H; Ohta T; Kaneko S
J Hepatol; 2009 Jan; 50(1):100-10. PubMed ID: 19008011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
